Evidence map›Paper›PMID 32906770›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Medicinal Cannabis and Synthetic Cannabinoid Use.

Simona Pichini, Alfredo Fabrizio Lo Faro, Francesco Paolo Busardò, Raffaele Giorgetti

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Simona PichiniDepartment of Excellence of Biomedical Sciences and Public Health, "Politecnica delle Marche" University of Ancona, Via Tronto 10/a, 60126 Ancona, Italy.
Alfredo Fabrizio Lo FaroAnalytical Pharmacotoxicology Unit, National Centre on Addiction and Doping, Istituto Superiore di Sanità V.Le Regina Elena 299, 00161 Rome, Italy.
Francesco Paolo BusardòDepartment of Excellence of Biomedical Sciences and Public Health, "Politecnica delle Marche" University of Ancona, Via Tronto 10/a, 60126 Ancona, Italy.
Raffaele GiorgettiDepartment of Excellence of Biomedical Sciences and Public Health, "Politecnica delle Marche" University of Ancona, Via Tronto 10/a, 60126 Ancona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis products have been used for centuries by humans for recreational and medical purposes. Resent research, proposed the promising therapeutic potential of cannabis and related cannabinoids for a wide range of medical conditions, including psychiatric and neurological diseases. This Special Issue presents the latest updates on medicinal cannabis and synthetic cannabinoids pharmacology, toxicology and new analytical methods to identify and quantify these compounds in conventional and non-conventional biological matrices. Moreover, it provides current data regarding their adverse effects, safety, application for medical purposes and their harmful effects.

Indexed as

CannabinoidsCannabisMedical MarijuanaNervous System DiseasesHumansCannabinoidsMedical Marijuanagas chromatography-mass spectrometryhigh-resolution mass spectrometryliquid chromatographysynthetic cannabinoidsurine

Identifiers

PMID32906770
PMCPMC7558594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.